Scinai Immunotherapeutics (SCNI) Payables (2015 - 2026)
Scinai Immunotherapeutics (SCNI) posted Payables of $779000.0 for Q1 2026, up 106.45% sequentially from -$12.1 million in Q4 2025.
Scinai Immunotherapeutics (SCNI) Payables (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Payables for 12 years, with the latest figure at $779000.0 in Q1 2026.
- Quarterly Payables changed N/A year-over-year to $779000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $779000.0 (changed N/A YoY) and the FY2025 annual result came in at -$12.1 million, down 1301.39% from the prior year.
- Payables advanced to $779000.0 in Q1 2026 per SCNI's latest filing, from -$12.1 million in the prior quarter.
- Over five years, Payables peaked at $1.6 million in Q4 2022 and troughed at -$12.1 million in Q4 2025.
- A 5-year average of -$31200.0 and a median of $659000.0 in 2025 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2025: Payables soared 83.84% in 2023, then plunged 1301.39% in 2025.
- Over 5 years, Payables stood at $1.6 million in 2022, then plunged by 47.66% to $849000.0 in 2023, then grew by 18.49% to $1.0 million in 2024, then slumped by 1301.39% to -$12.1 million in 2025, then surged by 106.45% to $779000.0 in 2026.
- According to Business Quant data, Payables over the past three periods registered $779000.0, -$12.1 million, and $659000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | 35.57 Mn |
| 10 | Scinai Immunotherapeutics | 12.68 Mn | -3.10 Bn | -1.12 Mn | 779,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 779,000.00 |
| Dec 31, 2025 | -12.09 Mn |
| Jun 30, 2025 | 659,000.00 |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 430,000.00 |
| Jun 30, 2024 | 658,000.00 |
| Mar 31, 2024 | 928,000.00 |
| Dec 31, 2023 | 849,000.00 |
| Sep 30, 2023 | 546,000.00 |
| Jun 30, 2023 | 651,000.00 |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Sep 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 588,000.00 |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 2.64 Bn |
| Mar 31, 2021 | 2.09 Bn |
| Dec 31, 2020 | 1.87 Bn |